Celldex Therapeutics CLDX
$27.42 −$0.54 (-1.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 -0.07%
Open$27.01
Prev close$27.96
Day range$26.64 – $28.43
Volume1.72M
Market cap$2.15B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±6.9%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+11.3%
Worst reaction-21.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2023/Q4 | 26 Feb 2024 | After Market | ±16.1% | +5.83% | Within range |
| 2021/Q4 | 28 Feb 2022 | After Market | ±17.3% | +5.62% | Within range |
| 2020/Q2 | 6 Aug 2020 | None | ±33.4% | -4.87% | Within range |
| 2019/Q2 | 7 Aug 2019 | After Market | – | +2.31% | – |
| 2018/Q4 | 7 Mar 2019 | After Market | – | +10.87% | – |
| 2018/Q2 | 8 Aug 2018 | After Market | – | -6.76% | – |
| 2017/Q4 | 7 Mar 2018 | None | – | +11.34% | – |
| 2017/Q2 | 8 Aug 2017 | None | – | -1.17% | – |
| 2016/Q4 | 14 Mar 2017 | After Market | – | +3.33% | – |
| 2016/Q2 | 8 Aug 2016 | None | – | -3.00% | – |
| 2015/Q4 | 25 Feb 2016 | Pre Market | – | +0.58% | – |
| 2015/Q2 | 10 Aug 2015 | After Market | – | -20.56% | – |
| 2014/Q4 | 24 Feb 2015 | Pre Market | – | +2.93% | – |
| 2014/Q3 | 4 Nov 2014 | After Market | – | -20.99% | – |
| 2014/Q2 | 6 Aug 2014 | None | – | -0.52% | – |
| 2013/Q4 | 3 Mar 2014 | None | – | -10.06% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$82.25M-11.7% YoY
Net profit-$75.56M-12.7% YoY
Diluted EPS-$0.96+5.0% YoY
Free cash flow-$66.70M-35.9% YoY
Operating cash flow-$65.04M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Operating margin-211,684.8%
Net margin-195,608.9%
Return on equity-49.5%
Return on assets-45.1%
Return on invested capital-49.0%
Current ratio10.97
Liabilities / assets10.0%
Cash & investments$650.32M
Total debt$8.43M
Net cash (debt)$641.89M
No comments yet — be the first to weigh in on CLDX.
Sign in to join the discussion.